409
Participants
Start Date
December 7, 2018
Primary Completion Date
March 24, 2020
Study Completion Date
March 24, 2020
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment.
RCCA MD Inc., Bethesda
CAMC Clinical Trials Center, Charleston
East Carolina University Brody School of Medicine, Greenville
FirstHealth Outpatient Cancer Center, Pinehurst
Lexington Medical Center, West Columbia
Spartanburg Regional Healthcare District, Spartanburg
Bon Secours St Francis Cancer Center, Greenville
Mid-Florida Hematology and Oncology Center, Orange City
Baptist Health Louisville, Louisville
Baptist Health Lexington, Lexington
St. Elizabeth Medical Center, Edgewood
Baptist Health Paducah, Paducah
Indiana Blood and Marrow Transportation, Indianapolis
Cancer Research Consortium of West Michigan, Grand Rapids
ProHealth Care, Oconomowoc
Dean Clinic - Fort Atkinson Specialty Services, Fort Atkinson
HealthPartner Institute, Bloomington
Rapid City Regional Hospital, Rapid City
Orchard Healthcare Research, Inc., Skokie
PMG Research, INC, Downers Grove
Illinois CancerCare-Peoria, Peoria
Carle Cancer Center NCI, Urbana
Mercy St. Louis, St Louis
Mercy Joplin, Joplin
Mercy Springfield, Springfield
CARTI Cancer Center, Little Rock
Mercy Fort Smith, Fort Smith
Mercy Oklahoma City, Oklahoma City
Community Cancer Trials of Utah, Ogden
North County Oncology, Oceanside
Alliance Research Centers, Laguna Hills
Marin Cancer Care, Greenbrae
Wenatchee Valley Hospital, Wenatchee
Middlesex Hospital, Middletown
The Stamford Hospital, Stamford
Lead Sponsor
Exact Sciences Corporation
INDUSTRY